Aethlon Medical is the developer of the Hemopurifier, a first-in-class medical device to treat infectious disease. The Hemopurifier addresses the largest opportunity in infectious disease, the treatment of drug and vaccine resistant viruses. The Hemourifier is a novel multi-patented platform technology designed for the single use removal of viral pathogens from blood. Regulatory and commercialization initiatives in the United States are focused on bioterror threats, while international initiatives are directed towards naturally evolving pandemic threats, and chronic infectious disease conditions including Hepatitis-C (HCV) and the Human Immunodeficiency Virus (HIV). Aethlon Medical is located in San Diego.